Cite
HARVARD Citation
Sahre, M. et al. (2021). Evaluating Patients With Impaired Renal Function During Drug Development: Highlights From the 2019 US FDA Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting. Clinical pharmacology & therapeutics. 110 (2), pp. 285-288. [Online].